Orphagen Pharmaceuticals
Orphagen develops new classes of small molecule therapeutics for the treatment of heart disease, HIV/AIDS, prostate cancer, and other major diseases.
Orphagen intends to become an industry leader in providing small molecule leads to a class of novel targets from the human genome known as orphan nuclear receptors.
|
While financial institutions have individually increased the level of resources towards combating anti-money laundering, it is AML Share's contention that an enterprise approach, while necessary, is insufficient to find more subtle and sophisticated transactions.
As the industry has in the past addressed common problems through co-operation, AML Share is facilitating an industry solution and has developed proprietary technology that assists financial institutions to share 314(b) information within a secure information network.
|
HealthCare Intelligence was launched in 2003 to provide healthcare organizations accurate management accounting methodologies that allow for a precise understanding of the full range of clinical data processes, their attendant service costs and the relationship to the resources required to the deliver quality patient care.
|
Trellis Solutions develops professional tools for converting and preparing HTML and text documents.
Trellis' product line includes HTML Ease Pro, and Edit Ease. HTML Ease Pro is a powerful HTML document preparation tool that quickly converts documents from almost any source into HTML. HTML Ease is the only program on the market that can convert complex financial and statistical tables into HTML with just a few clicks.
|
